Table 1: Baseline cognitive function test results, April 2022
The molecule was first identified and studied by the Sikiric research group in Croatia starting in the early 1990s, and the bulk of the preclinical evidence base comes from more than three decades of rat and rodent studies showing consistent tissue-repair, anti-inflammatory, and gastroprotective effects
But in a world where information comes hard and fast it is very difficult to decipher what works and what doesnt, what to take, and what not to, when it comes to your health
While high-dose oral tablets (1,000 mcg+) can work for some via "passive diffusion," the IV route bypasses the entire digestive system
BPC-157 demonstrates unusual stability for a peptide, with activity confirmed via multiple administration routes in rat models[18]